drugset / Trial / NCT02028533

Cocaine Opioid Oxytocin Option - Limited

NCT02028533

Phase 1 Completed 30 enrolled University of California, San Francisco
RandomizedSingle-groupQuadruple-blindOther

Summary

This is a pilot feasibility study assessing the tolerability of chronic administration of intranasal oxytocin to patients receiving methadone at an opioid replacement clinic who are actively using cocaine.

Timeline

Start
2014-07
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 40 iu Intranasal